Program

Day 2 September 16 (Wed)

Session

U.S. Medical Device Market Entry Seminar with TMC
Time Title Speaker
09:30 – 09:35 (05’) Opening Remarks Jung Younghoon
KHIDI
Planning Director
09:35 – 10:35 (60’) From Innovation to Commercialization Success: An Integrated Strategy for U.S. Healthcare Market Adoption Ruba Sarris Sawaya
MediStrat360 LLC
CEO & Managing Partner
10:35 – 11:35 (60’) U.S. Healthcare Market Access and Adoption Strategies: IDN & GPO David McDonough
Texas Medical Center(TMC)
Entrepreneur in Residence
11:35 – 12:05 (30’) Technology Adoption at US Hospital Systems Bryan Mcrae
University of Utah Health
M.D
12:05 – 12:30 (25’) Q&A

Speakers

You can click on each speaker to view their Professional Experience and Abstract.

  • Ruba Sarris Sawaya
    09:35 - 10:35 From Innovation to Commercialization Success: An Integrated Strategy for U.S. Healthcare Market Adoption
    Ruba Sarris Sawaya
    MediStrat360 LLC
    CEO & Managing Partner
    Close
    Ruba Sarris Sawaya
    Ruba Sarris Sawaya

    MediStrat360 LLC
    CEO & Managing Partner

    09:35 - 10:35
    • Professional Experience

      She is the Managing Partner of MediStrat360, the Chief Operating Officer (COO) of Otricath, and a medical device commercialization advisor at the Texas Medical Center. For more than 25 years, she has collaborated with medical technology companies, investors, and public‑sector organizations to accelerate the successful adoption of innovative medical technologies through integrated regulatory, clinical, reimbursement, and commercialization strategies.

    • Abstract

      This presentation explores the clinical evidence, reimbursement and market access requirements, stakeholder strategies, and commercialization preparations necessary for success in the U.S. market after obtaining FDA clearance. It will address integrated commercialization strategies that connect regulatory approval, reimbursement, and hospital adoption, as well as common gaps companies often overlook during U.S. market preparation.

  • David McDonough
    10:35 - 11:35 U.S. Healthcare Market Access and Adoption Strategies: IDN & GPO
    David McDonough
    Texas Medical Center, Medical Device Labs
    Enterpreneur in Residence
    Close
    David McDonough
    David McDonough

    Texas Medical Center, Medical Device Labs
    Enterpreneur in Residence

    10:35 - 11:35
    • Professional Experience

      David McDonough is a medical device commercialization expert with 35 years of experience in the U.S. healthcare market and a resident entrepreneur at the Texas Medical Center’s medical device innovation institute. He is the Co Founder and CEO of Convergent Medical and currently supports U.S. market entry for medical device companies in the Netherlands (Spatium Medical) and Australia (Roam Technologies). He is an active speaker on U.S. market entry and adoption strategies.

    • Abstract

      This presentation examines how medical devices are purchased, contracted, and scaled within the U.S. healthcare system. Focusing on IDNs and GPOs, it will detail purchasing structures, contracting pathways, and practical adoption strategies—from initial evaluation to post adoption utilization and broader market expansion.

  • Bryan Mcrae
    11:35 - 12:05 Technology Adoption at US Hospital Systems
    Bryan Mcrae
    University of Utah Health
    M.D
    Close
    Bryan Mcrae
    Bryan Mcrae

    University of Utah Health
    M.D

    11:35 - 12:05
    • Professional Experience
      • To be updated
    • Abstract

      This presentation examines how medical devices are evaluated and approved for purchase within U.S. hospitals, focusing on the role of the Value Analysis Committee (VAC). It will address clinical, operational, and economic value assessments, the roles of key stakeholders, and the requirements companies must prepare to meet in order to achieve hospital adoption.

    ※ 경력·초록 상세 내용은 연사 확정 후 업데이트될 예정입니다.